Return to QS93 Overview

Atrial fibrillation [QS93]

Measuring the use of this guidance

Statement: 1

Adults with non‑valvular atrial fibrillation and a CHA2DS2-VASC stroke risk score of 2 or above are offered anticoagulation.

Quality standard measure: Proportion of adults with non‑valvular atrial fibrillation and a CHA2DS2‑VASC stroke risk score of 2 or above who receive anticoagulation.
What was measured: AF007: In those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more, the percentage of patients who are currently treated with anti-coagulation drug therapy.
Data collection end: March 2016
77.9%
Data collection end: March 2017
81.2%
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.



 Return to QS93 Overview